Navigation Links
Researchers identify key proteins needed for ovulation
Date:5/14/2009

Researchers from the National Institutes of Health and other institutions have identified in mice two proteins essential for ovulation to take place.

The finding has implications for treating infertility resulting from a failure of ovulation to occur as well as for developing new means to prevent pregnancy by preventing the release of the egg.

The proteins, called ERK1 and ERK2, appear to bring about the maturation and release of the egg.

The study, appearing in the May 15 issue of Science, was funded in part by two NIH institutes, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Cancer Institute (NCI).

"Ovulation results from a complex interplay of chemical sequences," said Duane Alexander, M.D., director of the NICHD. "The researchers have identified a crucial biochemical intermediary controlling the release of the egg. The finding advances our understanding and may one day contribute to new treatments for infertility as well as new ways to prevent pregnancy from occurring."

The study's senior author, JoAnne Richards, Ph.D., of Baylor College of Medicine, worked with Esta Sterneck and Peter Johnson, of the NCI's Center for Cancer Research; with Heng-Yu Fan and Zhilin Liu of Baylor; Masayuki Shimada, of Hiroshima University, in Japan; and Stephen Hedrick, of the University of California, San Diego.

The immature egg is contained inside a covering of cells, known as the ovarian follicle. The follicle is made largely of cells known as granulosa cells. Each month, the pituitary gland releases follicle-stimulating hormone and luteinizing hormone which cause the egg and the ovarian granulosa cells surrounding it to grow and develop into a mature follicle. Midway through the woman's monthly cycle, the pituitary releases a large surge of luteinizing hormone, which causes the follicle to rupture, releasing the egg cell. The granulosa cells in the ruptured follicle transform into luteal cells.

Previously, researchers did not know how luteinizing hormone triggered the ovary's release of the egg and the production of progesterone by the granulosa cells. In the current study, the researchers discerned that luteinizing hormone appears to signal the release of molecules known as extracellular-regulated protein kinases 1 and 2 (ERK 1 and ERK 2). In turn, these molecules trigger a chain of chemical sequences that bring about the release of the egg, the transformation of granulosa cells into luteal cells, and the production of progesterone.

ERK1 and ERK2 are a critical nexus between the surge in luteinizing hormone and ovulation, explained the NICHD project officer for the study, Louis V. De Paolo, Ph.D., chief of the NICHD Reproductive Sciences Branch.

"This a key chemical pathway that affects not only ovulation, but egg cell maturation and granulosa cell differentiation into luteal cells," Dr. De Paolo said.

Although ERK1 and ERK2 are essential intermediaries to ovulation, there are other molecules, yet to be discovered, which presumably also play important roles in the process. The Reproductive Sciences Branch is supporting studies to decipher these other intricate chemical sequences.

"We're still at the tip of the iceberg," Dr. De Paolo said. "We need to understand it all."

While understanding the function of ERK1 and ERK 2 may yield important information for treating infertility in women, this understanding might also lead to ways to prevent ovulation from occurring, for the development of new means of contraception Dr. De Paolo said.

To conduct the study, Dr. Richards and her colleagues used mice that lacked the genes needed to produce ERK1 and ERK2. The ovaries of these mice still produced eggs, but did not release them after exposure to luteinizing hormone. Moreover, the granulosa cells did not transform into luteal cells and begin producing progesterone, the normal course of events when the two genes are present.

In contrast, mice with working versions of the genes for ERK1 and ERK 2 were fertile.

To date, no other genes have been discovered that are essential to both ovulation and the conversion of the other cells to progesterone producers, according to Dr. Richards. An important role of the ERK1 and ERK2, she said, appears to be to stop the granulosa cells from growing, so that they take on their final role of producing progesterone.


'/>"/>

Contact: Robert Bock or Marianne Glass Miller
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development
Source:Eurekalert

Related medicine news :

1. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
2. Researchers study the human factor in spread of pandemic illness
3. Body movements can influence problem solving, researchers report
4. Researchers identify the gene responsible for a rare form of congenital anemia
5. K-State Researchers and Their Partners Making it Easier for Rural Kansans of All Ages to Stay Healthy Despite Limited Access to Facilities Like Bike Trails, Gyms
6. IBM and Medical Researchers Launch Effort To Find Flu Drug Treatments
7. Children with concussions require follow-up care before returning to play, say researchers
8. Children with Concussions Require Follow-up Care Before Returning to Play, Say Researchers
9. Cancer-obesity link discovery by MSU researchers could aid prevention efforts
10. Researchers design unique method to induce immunity to certain STDs
11. Researchers to Monitor Public Perception of Swine Flu Outbreaks Using Technology from Realtime Search Engine, OneRiot
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
(Date:12/2/2016)... Delaware (PRWEB) , ... December 02, 2016 , ... ... released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps ... sample entry through labeling, storing, shipping and disposal. The new version is a ...
(Date:12/2/2016)... ... 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, ... Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in 1934 ... details line up exactly with Bible Prophecy – a protected way for those who ...
(Date:12/2/2016)... ... December 02, 2016 , ... Date aired: November 28, 2016 ... Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein , Sharon Kleyne, America’s leading ... Climate Change and Your Health radio program syndicated on Voice of America, welcomed ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... GARDENS, N.Y. , Dec. 2, 2016  LifeVac, ... will be included in the Emergency Response Training and ... are very excited to have LifeVac become part of ... Lih , Founder and CEO of LifeVac. "Having an ... LifeVac safely and effectively will help leverage our efforts ...
(Date:12/2/2016)... 2, 2016 According to ... Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, ... Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021" ... at USD 60.22 Billion in 2016. This market ... 5.5% during the forecast period (2016-2021) to reach ...
(Date:12/2/2016)... -- In the first ever attempt to include phytocannabinoids ... C. sativa, the Hebrew University in Jerusalem, the University ... , the Universita` del Piemonte Orientale and Phytoplant Research ... unified inventory of phytocannabinoids of different botanical origin. ... chemical and structural diversity of phytocannabinoids. As a result ...
Breaking Medicine Technology: